LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
3.1623
4.36 84.90 768 322 2.3809 2.1380
MN20160318_Q02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
4.36 84.90 1 322 0.0031 -0.9004
MN20160318_Q02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
4.36 84.90 793 322 2.4584 2.1906
MN20160318_Q02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
6.06 84.90 1 365 0.0027 -0.8787
MN20160318_Q02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
6.06 84.90 818 365 2.2383 1.9322
MN20160318_Q02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
6.06 84.90 3 365 0.0082 -0.7955
MN20160318_Q02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
6.06 84.90 855 365 2.3396 1.9944
MN20160318_Q02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
7.77 84.90 1 411 0.0024 -0.8579
MN20160318_Q02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
7.77 84.90 864 411 2.1010 1.7713
MN20160318_Q02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
7.77 84.90 2 411 0.0049 -0.8073
MN20160318_Q02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
7.77 84.90 888 411 2.1593 1.8048
MN20160318_Q02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
9.47 84.90 1 447 0.0022 -0.8431
MN20160318_Q02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
9.47 84.90 896 447 2.0026 1.6718
MN20160318_Q02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
9.47 84.90 2 447 0.0045 -0.7905
MN20160318_Q02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
9.47 84.90 917 447 2.0495 1.6977
MN20160318_Q02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
11.18 84.90 2 492 0.0041 -0.7719
MN20160318_Q02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
11.18 84.90 969 492 1.9681 1.6120
MN20160318_Q02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
11.18 84.90 9 492 0.0183 -0.5873
MN20160318_Q02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
11.18 84.90 958 492 1.9457 1.6003
MN20160318_Q02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
12.88 84.90 4 531 0.0075 -0.6850
MN20160318_Q02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
12.88 84.90 954 531 1.7966 1.4959
MN20160318_Q02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
12.88 84.90 13 531 0.0245 -0.5081
MN20160318_Q02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
12.88 84.90 994 531 1.8719 1.5350
MN20160318_Q02
K04
MCF 10A-H2B-mCherry Neratinib
3.1623
14.58 84.90 5 663 0.0075 -0.6151
MN20160318_Q02
J14
MCF 10A-H2B-mCherry Neratinib
3.1623
14.58 84.90 978 663 1.4742 1.2796
MN20160318_Q02
J14